Captrust Financial Advisors Cytokinetics Inc Transaction History

Captrust Financial Advisors

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.88 - $83.49 $79,242 - $246,128	-2,948 Reduced 19.39%	12,258 $1.02 Million
Q3 2023 Nov 14, 2023	BUY	$29.46 - $36.61 $148,331 - $184,331	5,035 Added 49.5%	15,206 $447,000
Q2 2023 Aug 14, 2023	SELL	$32.62 - $40.75 $587 - $733	-18 Reduced 0.18%	10,171 $331,000
Q1 2023 May 15, 2023	SELL	$33.36 - $45.71 $22,918 - $31,402	-687 Reduced 6.32%	10,189 $358,000
Q4 2022 Feb 15, 2023	BUY	$35.77 - $51.11 $239,623 - $342,385	6,699 Added 160.38%	10,876 $498,000
Q3 2022 Nov 16, 2022	BUY	$38.54 - $54.52 $11,716 - $16,574	304 Added 7.85%	4,177 $202,000
Q2 2022 Aug 16, 2022	SELL	$33.93 - $48.92 $1,255 - $1,810	-37 Reduced 0.95%	3,873 $152,000
Q1 2022 May 16, 2022	BUY	$29.74 - $46.0 $51,598 - $79,810	1,735 Added 79.77%	3,910 $144,000
Q4 2021 Feb 14, 2022	BUY	$34.35 - $46.38 $618 - $834	18 Added 0.83%	2,175 $99,000
Q3 2021 Nov 16, 2021	BUY	$18.54 - $35.74 $797 - $1,536	43 Added 2.03%	2,157 $77,000
Q2 2021 Aug 16, 2021	SELL	$19.79 - $26.99 $336 - $458	-17 Reduced 0.8%	2,114 $42,000
Q1 2021 May 17, 2021	BUY	$18.57 - $25.68 $36,972 - $51,128	1,991 Added 1422.14%	2,131 $50,000
Q4 2020 Feb 16, 2021	SELL	$15.26 - $28.61 $3,967 - $7,438	-260 Reduced 65.0%	140 $3,000
Q3 2020 Nov 17, 2020	BUY	$20.58 - $28.96 $8,232 - $11,584	400 New	400 $9,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.49B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.